Evidence map›Paper›PMID 32560261›Full record

ReviewInternational journal of molecular sciences2020

Cellular Models and Assays to Study NLRP3 Inflammasome Biology.

Giovanni Zito, Marco Buscetta, Maura Cimino, Paola Dino, Fabio Bucchieri, Chiara Cipollina

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. The Immunopathogenesis of uveitis.Frontiers in medicine · 2026
    Review
  3. Article
  4. NLRP3 inflammasome expression in pediatric asthma: sputum-based insights, inflammatory mechanisms, and targeted therapeutic strategies.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Giovanni ZitoFondazione Ri.MED, via Bandiera 11, 90133 Palermo, Italy.
Marco BuscettaFondazione Ri.MED, via Bandiera 11, 90133 Palermo, Italy.
Maura CiminoFondazione Ri.MED, via Bandiera 11, 90133 Palermo, Italy.
Paola DinoDipartimento di Biomedicina Sperimentale, Neuroscenze e Diagnostica Avanzata (Bi.N.D), University of Palermo, via del Vespro 129, 90127 Palermo, Italy.
Fabio BucchieriDipartimento di Biomedicina Sperimentale, Neuroscenze e Diagnostica Avanzata (Bi.N.D), University of Palermo, via del Vespro 129, 90127 Palermo, Italy.
Chiara CipollinaFondazione Ri.MED, via Bandiera 11, 90133 Palermo, Italy.
Ri.MED · ITUniversity of Palermo · ITInstitute for Biomedical Research and Innovation · IT

Funding

Programme Cohesion Development Fund 2014/2020 - Grant Patto per il Sud G77B17000110001
6 · The paper itself

Abstract

The NLRP3 inflammasome is a multi-protein complex that initiates innate immunity responses when exposed to a wide range of stimuli, including pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). Inflammasome activation leads to the release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18 and to pyroptotic cell death. Over-activation of NLRP3 inflammasome has been associated with several chronic inflammatory diseases. A deep knowledge of NLRP3 inflammasome biology is required to better exploit its potential as therapeutic target and for the development of new selective drugs. To this purpose, in the past few years, several tools have been developed for the biological characterization of the multimeric inflammasome complex, the identification of the upstream signaling cascade leading to inflammasome activation, and the downstream effects triggered by NLRP3 activation. In this review, we will report cellular models and cellular, biochemical, and biophysical assays that are currently available for studying inflammasome biology. A special focus will be on those models/assays that have been used to identify NLRP3 inhibitors and their mechanism of action.

Indexed as

AlarminsAnimalsHumansImmunity, InnateInflammasomesInterleukin-18Interleukin-1betaModels, BiologicalNLR Family, Pyrin Domain-Containing 3 ProteinPathogen-Associated Molecular Pattern MoleculesPyroptosisSignal TransductionAlarminsIL18 protein, humanIL1B protein, humanInflammasomesInterleukin-18Interleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPathogen-Associated Molecular Pattern Moleculesbiochemical assaysbiophysical assayscell modelsinflammasomeNLRP3NLRP3 inhibitorsread-outs

Identifiers

PMID32560261
PMCPMC7352206
OpenAlexW3035340427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.